Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | JAK2 | O60674 | 1/20 | 0.37 |
| ▸ | JAK3 | P52333 | 1/20 | 0.37 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.34 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.34 |
| ▸ | REN | P00797 | 1/20 | 0.34 |
| ▸ | MAT2A | P31153 | 2/20 | 0.33 |
| ▸ | METAP2 | P50579 | 1/20 | 0.31 |
| ▸ | TGM2 | P21980 | 1/20 | 0.31 |
| ▸ | HMGCR | P04035 | 2/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | UBE2N | P61088 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20904364 | 1.00 | KDM4E (0.38) | KDM4EATML3MBTL1JAK2JAK3 | |
| SCHEMBL20904309 | 0.95 | KDM4E (0.40) | KDM4EATML3MBTL1JAK2JAK3 | |
| SCHEMBL20904311 | 0.95 | KDM4E (0.40) | KDM4EATML3MBTL1JAK2JAK3 | |
| SCHEMBL20904312 | 0.94 | KDM4E (0.38) | KDM4EATML3MBTL1JAK2JAK3 | |
| SCHEMBL20904335 | 0.93 | KDM4E (0.37) | KDM4EATML3MBTL1JAK2JAK3 | |
| SCHEMBL20904319 | 0.92 | L3MBTL1 (0.39) | KDM4EATML3MBTL1JAK2JAK3 | |
| SCHEMBL26539067 | 0.92 | L3MBTL1 (0.44) | KDM4EATML3MBTL1JAK2JAK3 | |
| SCHEMBL26540023 | 0.91 | L3MBTL1 (0.41) | KDM4EATML3MBTL1JAK2JAK3 | |
| SCHEMBL26540559 | 0.90 | L3MBTL1 (0.40) | KDM4EATML3MBTL1JAK2JAK3 | |
| SCHEMBL20904336 | 0.90 | KDM4E (0.42) | KDM4EATML3MBTL1JAK2JAK3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10937967-B2 | Amine-based compound and organic light-emitting device including the amine-based compound | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-03-02 | — | — | US | disclosed |
| US-20190115543-A1 | AMINE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE AMINE-BASED COMPOUND | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-04-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10937967-B2 | Amine-based compound and organic light-emitting device including the amine-based compound | AOC2, AOC1, SAT1 | KDM4E 495/4885ATM 792/4885L3MBTL1 665/4885 |
| US-20190115543-A1 | AMINE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE AMINE-BASED COMPOUND | AOC2, AOC1, SAT1 | KDM4E 495/4885ATM 792/4885L3MBTL1 665/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.